TVTX
NASDAQ · Biotechnology
Travere Therapeutics Inc
$54.98
-0.91 (-1.63%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+82.84%
1Y
+225.13%
YTD
+39.12%
Open$54.82
Previous Close$55.89
Day High$56.00
Day Low$53.42
52W High$60.10
52W Low$15.03
Volume—
Avg Volume1.19M
Market Cap5.33B
P/E Ratio—
EPS$-0.27
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$32.84
Above
SMA 200
$24.79
Above
RSI (14)
40.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-32.4% upside
Current
$54.98
$54.98
Target
$37.15
$37.15
$26.93
$37.15 avg
$48.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 524.25M | 396.32M | 873.79M |
| Net Income | -27,295,544 | -18,571,204 | 83.63M |
| Profit Margin | -5.2% | -5.0% | 9.6% |
| EBITDA | -3,859,879 | -2,772,063 | 111.75M |
| Free Cash Flow | — | — | 68.75M |
| Rev Growth | +32.3% | +32.3% | +12.5% |
| Debt/Equity | 2.71 | 2.71 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |